Utah Medical Products (UTMD) Reports Q4 EPS of $1.25

Utah Medical Products (NASDAQ: UTMD) reported Q4 EPS of $1.25. Revenue for the quarter came in at $13.58 million, versus $0 reported last year.

For earnings history and earnings-related data on Utah Medical Products (UTMD) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Rivian reports Q3 2026 production of 19,751 vehicles
• CIGNA (CI) PT Raised to $370 at Piper Sandler